We currently manufacture our lead product candidate, Specifid™ (formerly FavId®), for our ongoing clinical trials in our 26,000 square foot, state-of-the-art, multi-product cGMP manufacturing facility in San Diego. The pilot manufacturing facility is housed in our 80,000 square foot building, which we have expanded for commercial-scale manufacturing of Specifid. Upon validation, the 80,000-square foot facility will be devoted exclusively to manufacturing, and is intended to give us the capacity to produce Specifid for up to 4,000 patients per year to meet commercial needs while continuing to support additional clinical trials. In addition, we have leased an adjacent 48,000-square foot facility for our corporate headquarters and warehousing operations.